• 3X (DYKDDDDK) Peptide for Ferroptosis Assays

  2026-09-11

  The 3X (DYKDDDDK) Peptide offers a sensitive route to purify and detect engineered proteins while preserving assay interpretability. This article explains how to deploy the 3X FLAG peptide in hypoxia–ferroptosis research, with emphasis on translation-aware controls, metal sensitivity, and orthogonal validation.

• Angiotensin II in Reliable Cell Assays

  2026-09-11

  Learn how Angiotensin II (SKU A1042) can improve the design, interpretation, and reproducibility of cell viability, proliferation, and cytotoxicity studies. This scenario-based guide covers mechanism, solvent compatibility, protocol optimization, cross-domain interpretation, and practical vendor selection.

• Phenothiazines, ROS, and Macrophage Antibacterial Activity

  2026-09-10

  The reference study identifies phenothiazines as host-directed antibacterial leads that strengthen macrophage defenses against intracellular bacteria through reactive oxygen species accumulation, lysosomal activity, and autophagy. Its inhibitor and in vivo experiments support a host-response mechanism rather than conventional direct antibiotic action, while also defining important limits for translating phenothiazine pharmacology into infection research.

• DiscoveryProbe Protease Inhibitor Library: Mechanisms

  2026-09-10

  The DiscoveryProbe Protease Inhibitor Library enables mechanism-aware protease inhibition studies across biochemical and cellular models. This article connects its screening utility with a dynamic assay-design lesson from the DdmDE defense-system study, helping researchers distinguish target engagement from downstream cleavage.

• Vancomycin Workflows for MRSA Research

  2026-09-09

  Build more reproducible susceptibility, bactericidal, and resistance-mechanism assays with Vancomycin, a glycopeptide antibiotic that targets peptidoglycan precursor binding. This guide connects comparative susceptibility evidence with practical solvent controls, inoculum design, endpoint selection, and troubleshooting for MRSA and Clostridium difficile infection research.

• RIPA Lysis Buffer Strong for Protein Workflows

  2026-09-09

  RIPA Lysis Buffer Strong combines powerful detergent-mediated extraction with the flexibility to add a customized inhibitor cocktail. This makes it useful for Western blotting, immunoprecipitation, ELISA sample preparation, and selected kinase workflows involving animal cells or tissues.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide

  2026-09-08

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides fluorescent detection of goat IgG primary antibodies in ICC/IF, tissue staining, flow cytometry, and compatible ELISA workflows. It should not be treated as a universal secondary antibody: confirm goat primary-antibody compatibility, control Cy3 spectral overlap, and validate assay-specific dilution and incubation conditions before interpreting results.

• Angiotensin 1/2 (2-7): Assay Strategy

  2026-09-08

  Angiotensin 1/2 (2-7) is a defined peptide tool for dissecting renin-angiotensin signaling, vascular responses, and peptide-dependent receptor binding. This guide translates recent spike–receptor findings into practical assay-design, handling, and interpretation decisions.

• MPC, Lactate, and Histone Lactylation in CRC

  2026-09-07

  This 2025 study identifies mitochondrial pyruvate carrier (MPC) loss as a metabolic driver of lactate accumulation, histone lactylation, dendritic-cell dysfunction, and impaired antitumor immunity in colorectal cancer. Its experimental framework connects pyruvate handling to CD8+ T-cell activity and anti-PD-1 response, providing a useful model for studying metabolic-epigenetic regulation in the tumor microenvironment.

• Sumatriptan: From 5-HT1 Biology to Translation

  2026-09-07

  A translational perspective on Sumatriptan Succinate as a 5-HT1 receptor agonist, connecting receptor pharmacology and neuroinflammation research with a pediatric emergency-department pathway.

• Pyridostatin: From G4 Stabilization to Assay Logic

  2026-09-05

  Pyridostatin is a G-quadruplex stabilizer that connects DNA structure, telomere dysfunction, and disease phenotypes. This article develops an evidence-based assay framework that distinguishes established telomere applications from emerging RNA G-quadruplex and TDP-43 research.

• Perifosine (KRX-0401) for Reliable Cell Assays

  2026-09-04

  This scenario-based guide explains how Perifosine, SKU A8309, can support reproducible viability, proliferation, apoptosis, and Akt-pathway experiments. It connects reported concentration-dependent effects with practical handling, controls, endpoint selection, and evidence-aware interpretation.

• Novel Gemini QACs: Broad-Spectrum Biocidal Activity

  2026-09-04

  This Bioorganic Chemistry study synthesized and evaluated 16 octenidine-derived gemini quaternary ammonium compounds against bacteria, biofilms, fungi, and viruses. Several candidates outperformed octenidine or benzalkonium chloride in selected assays, while compounds 1 and 12 showed particularly useful combinations of antifungal activity, broad-spectrum efficacy, and reduced cytotoxicity.

• REV1–DHX36 and G-Quadruplex Replication

  2026-09-03

  The reference study identifies a direct REV1–DHX36 partnership that coordinates G-quadruplex unwinding, replication-fork progression, and suppression of single-stranded DNA gaps. Its findings place REV1 at the intersection of helicase recruitment, PrimPol restraint, replication fidelity, and ATM/ATR stress signaling, providing a mechanistic framework for studying genome instability.

• GDC-0068: A Spatial Akt–mTOR Assay Framework

  2026-09-03

  GDC-0068 (RG7440) is a selective pan-AKT inhibitor for dissecting how Akt controls mTORC1-dependent growth, survival, and transcription. This article presents a biomarker-aware assay framework that distinguishes pathway inhibition from compartment-specific causality.

8115 records 1/541 page Next 12345 下5页 Last page